The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PKC up-regulates the β-AR signaling cascade and, consequently, its primary effector PKA via phosphorylation of RKIP at S153 (10).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [10]
In the citing paper
“RKIP loss and/or dysregulation have been linked to many diseases, including metastatic lesions, asthma, Alzheimer’s disease, systemic inflammatory response syndrome, and heart disease (4–10).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [10]
In the citing paper
“Upon phosphorylation by protein kinase C (PKC) at S153, RKIP is released from Raf and inhibits GRK2, a member of the G protein coupled receptor kinase family that modulates the function of the β-AR (10, 13).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [10]
In the citing paper
“the number of beats per minute was determined before and 2 min after stimulation with 50 nM isoprenaline by an observer who was blind to the experimental protocol studied (10).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. L. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,103
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., et al. (1999) · Nature · doi:10.1038/43686 · Cited by 893
Ungerer, M., Böhm, M., Elce, J. S., Erdmann, E., & Lohse, M. J. (1993) · Circulation · doi:10.1161/01.cir.87.2.454 · Cited by 878
Self-citationPitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey, P. J., Kim, C., Benovic, J. L., Kwatra, M. M., Caron, M. G., & Lefkowitz, R. J. (1992) · Science · doi:10.1126/science.1325672 · Cited by 717
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
AbdAlla, S., Lother, H., & Quitterer, U. (2000) · Nature · doi:10.1038/35024095 · Cited by 503
Self-citationIncreased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
AbdAlla, S., Lother, H., el Massiery, A., & Quitterer, U. (2001) · Nature Medicine · doi:10.1038/nm0901-1003 · Cited by 496
Self-citationThe Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist
AbdAlla, S., Lother, H., Abdel-tawab, A. M., & Quitterer, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105253200 · Cited by 463
Self-citationSerine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
Mason, C. S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2137 · Cited by 457
Maudsley, S., Pierce, K. L., Zamah, A. M., Miller, W. E., Ahn, S., Daaka, Y., Lefkowitz, R. J., & Luttrell, L. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9572 · Cited by 407
Lohse, M. J., Benovic, J. L., Caron, M. G., & Lefkowitz, R. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39754-6 · Cited by 401
Self-citationYeung, K., Janosch, P., McFerran, B., Rose, D. W., Mischak, H., Sedivy, J. M., & Kolch, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3079-3085.2000 · Cited by 389
Corbit, K. C., Trakul, N., Eves, E. M., Diaz, B., Marshall, M., & Rosner, M. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210015200 · Cited by 360
Essential role of β-adrenergic receptor kinase 1 in cardiac development and function
Jaber, M., Koch, W. J., Rockman, H., Smith, B., Bond, R. A., Sulik, K. K., Ross, J., Lefkowitz, R. J., Caron, M. G., & Giros, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12974 · Cited by 341
Small interfering RNA and gene silencing in transgenic mice and rats
Hasuwa, H., Kaseda, K., Einarsdottir, T., & Okabe, M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03680-3 · Cited by 266
G-protein-coupled receptor kinase activity is increased in hypertension.
Gros, R., Benovic, J. L., Tan, C. M., & Feldman, R. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119381 · Cited by 219
Mechanisms of β-Adrenergic Receptor Desensitization and Resensitization
Lefkowitz, R. J., Pitcher, J., Krueger, K., & Daaka, Y. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60777-2 · Cited by 197
Kallal, L., Gagnon, A. W., Penn, R. B., & Benovic, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.322 · Cited by 165
Role of catenins in the development of gap junctions in rat cardiomyocytes
Wu, J., Tsai, R., & Chung, T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10390 · Cited by 85
AT 2 ‐Receptor activation regulates myocardial eNOS expression via the calcineurin‐NF‐AT pathway
Ritter, O., Schuh, K., Breden, M., Röthlein, N., Burkard, N., Hein, L., & Neyses, L. (2002) · The FASEB Journal · doi:10.1096/fj.02-0321fje · Cited by 75
Lu, Z., DiBlasio-Smith, E. A., Grant, K. L., Warne, N. W., LaVallie, E. R., Collins‐Racie, L. A., Follettie, M. T., Williamson, M. J., & McCoy, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5059 · Cited by 70
The Amino-terminal Domain of G-protein-coupled Receptor Kinase 2 Is a Regulatory Gβγ Binding Site
Eichmann, T., Lorenz, K., Hoffmann, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204795200 · Cited by 55
Self-citationYu, Q., Cheng, Z., Gan, X., Bao, G., Li, L., & Pei, G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731222.x · Cited by 30
Binding of Gβγ subunits to cRaf1 downregulates G-protein-coupled receptor signalling
Slupsky, J. R., Quitterer, U., Weber, C. K., Gierschik, P., Lohse, M. J., & Rapp, U. R. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80426-6 · Cited by 21
Self-citation
Cited by
A Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics
Liu, H., Sadygov, R. G., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac0498563 · Cited by 2,500
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
Kolch, W. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1743 · Cited by 1,070
Specialized ribosomes: a new frontier in gene regulation and organismal biology
Xue, S., & Barna, M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3359 · Cited by 703
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, E., & Lefkowitz, R. J. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 666
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate
Santos, S. D. M., Verveer, P. J., & Bastiaens, P. I. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1543 · Cited by 609
Metadata
- Authors
- Lorenz, K., Lohse, M. J., & Quitterer, U.
- Venue
- Nature
- Published
- 2003-12
- Volume
- 426
- Issue
- 6966
- Pages
- 574-579
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1975403276
- Cited by
- 384
- References
- 23
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.